{"id":2640,"date":"2021-02-10T03:08:05","date_gmt":"2021-02-10T03:08:05","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2640"},"modified":"2023-08-29T17:48:28","modified_gmt":"2023-08-29T17:48:28","slug":"avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2640","title":{"rendered":"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1"},"content":{"rendered":"<p>\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0c<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=AVE&amp;lang=cn\">Avecho Biotechnology (ASX: AVE)<\/a>\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002<\/p>\n<p>\u5728\u6b64\u4e4b\u524d\uff0c\u4e0a\u5468\u6709\u6d88\u606f\u79f0\uff0c<a href=\"http:\/\/smallcaps-production.test\/jazz-pharmaceuticals-gw-premium-offer-maturing-medicinal-cannabis-sector\/?lang=cn\">\u5168\u7403\u5de8\u5934Jazz Pharmaceuticals\u63d0\u51fa\u4ee572\u4ebf\u7f8e\u5143\u6536\u8d2dGW\u5236\u836f\u516c\u53f8<\/a>\uff0c\u540e\u8005\u62e5\u6709\u5927\u91cf\u7684\u5927\u9ebb\u7c7b\u5019\u9009\u836f\u7269\u3002GW\u8fd8\u62e5\u6709\u57fa\u4e8e\u5927\u9ebb\u7d20\u7684\u836f\u7269Epidiolex\uff0c\u8fd9\u662f\u7b2c\u4e00\u4e2a\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u7684\u57fa\u4e8e\u690d\u7269\u7684\u5927\u9ebb\u7d20\u836f\u7269\u3002<\/p>\n<p>\u968f\u7740\u5168\u7403\u5bf9\u5927\u9ebb\u7c7b\u836f\u7269\u7684\u5173\u6ce8\u518d\u6b21\u805a\u7126\uff0cAvecho\u83b7\u5f97\u4e86506\u4e07\u6fb3\u5143\u7684\u878d\u8d44\uff0c\u540c\u65f6\u4e5f\u83b7\u5f97\u4e86100\u4e07\u6fb3\u5143\u7684\u6295\u8d44\u57fa\u91d1Horizon 3 Biotech\u7684\u6ce8\u518c\u8d44\u91d1\u3002<\/p>\n<p>Avecho\u4ee5\u6bcf\u80a10.022\u6fb3\u5143\u7684\u4ef7\u683c\u53d1\u884c\u4e862.3\u4ebf\u80a1\u80a1\u7968\uff0c\u4ee5\u7b79\u96c6506\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\u3002\u671f\u6743\u7684\u6267\u884c\u4ef7\u683c\u4e3a\u6bcf\u80a10.035\u6fb3\u5143\uff0c\u6709\u6548\u671f\u4e3a2023\u5e7412\u670831\u65e5\u3002<\/p>\n<p>Peak Asset Management\u62c5\u4efb\u6b64\u6b21\u914d\u80a1\u7684\u4e3b\u7ecf\u7406\uff0c\u5e76\u627f\u9500\u4e86\u53e6\u5916400\u4e07\u6fb3\u5143\u3002\u52302\u67089\u65e5\u4ea4\u6613\u7ed3\u675f\u65f6\uff0c\u6b64\u6b21\u914d\u552e\u5df2\u6536\u5230\u8d85\u8fc72300\u4e07\u6fb3\u5143\u7684\u6295\u6807\u3002<\/p>\n<p>Avecho\u9996\u5e2d\u6267\u884c\u5b98Paul Gavin\u535a\u58eb\u8868\u793a\uff0c\u516c\u53f8\u201c\u975e\u5e38\u611f\u8c22\u201d\u73b0\u6709\u80a1\u4e1c\u3001\u65b0\u6210\u719f\u6295\u8d44\u8005\u548c\u4e13\u4e1a\u57fa\u91d1\u7684\u201c\u5927\u529b\u652f\u6301\u201d\u3002<\/p>\n<p>\u201c\u4e00\u6bb5\u65f6\u95f4\u4ee5\u6765\uff0c\u6211\u4eec\u4e00\u76f4\u5728\u89c2\u5bdf\u4eba\u4eec\u5bf9\u836f\u7528\u5927\u9ebb\u7d20\u7684\u5174\u8da3\u4e0d\u65ad\u589e\u957f\uff0c\u6211\u4eec\u6536\u5230\u7684\u53cd\u54cd\u8868\u660e\uff0c\u8fd9\u4e00\u9886\u57df\u6b63\u5728\u5f62\u6210\u5f3a\u5927\u7684\u5546\u4e1a\u52bf\u5934\u3002\u201d<\/p>\n<h2>\u5927\u9ebb\u7d20\u5236\u836f\u53d1\u5c55<\/h2>\n<p>Avecho\u5c06\u5229\u7528\u8fd9\u7b14\u8d44\u91d1\u8fdb\u4e00\u6b65\u5f00\u53d1\u548c\u6ce8\u518c\u8be5\u516c\u53f8\u65b0\u7684\u533b\u836f\u7ea7\u5927\u9ebb\u7d20\u4ea7\u54c1\u3002<\/p>\n<p>\u53bb\u5e74\u5e74\u5e95\uff0cAvecho\u542f\u52a8\u4e86\u57fa\u4e8e\u5176\u4e13\u5229\u836f\u7269\u9012\u9001\u7cfb\u7edfTPM(\u751f\u80b2\u915a\u78f7\u9178\u76d0\u6df7\u5408\u7269)\u7684\u53e3\u670d\u5927\u9ebb\u7d20\u5236\u5242\u7684\u4e34\u5e8a\u6d4b\u8bd5\u3002<\/p>\n<p>TPM\u8f93\u9001\u7cfb\u7edf\u662f\u4f7f\u7528\u72ec\u7279\u7684\u4e13\u5229\u548c\u4e13\u5229\u5de5\u827a\u4ece\u7ef4\u751f\u7d20E\u4e2d\u884d\u751f\u51fa\u6765\u7684\u3002<\/p>\n<p>\u6839\u636eAvecho\u7684\u8bf4\u6cd5\uff0cTPM\u53ef\u4ee5\u63d0\u9ad8\u836f\u7269\u548c\u8425\u517b\u7269\u8d28\u7684\u6eb6\u89e3\u5ea6\u4ee5\u53ca\u53e3\u670d\u3001\u76ae\u80a4\u548c\u900f\u76ae\u5438\u6536\u3002<\/p>\n<p>Avecho\u7684\u7814\u7a76\u662f\u6fb3\u5927\u5229\u4e9a\u6700\u5927\u7684\u836f\u7528\u5927\u9ebb\u4ea7\u54c1\u8fd0\u884c\u89c2\u5bdf\u6027\u7814\u7a76\u2014\u2014CA\u8bca\u6240\u89c2\u5bdf\u6027\u7814\u7a76\u7684\u4e00\u90e8\u5206\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u9884\u8ba1\uff0c\u8fd9\u6b21\u8bd5\u9a8c\u5c06\u5bf9\u4ea7\u54c1\u7684\u8fdb\u4e00\u6b65\u53d1\u5c55\u4ea7\u751f\u5f71\u54cd\uff0c\u5e76\u63d0\u4f9b\u771f\u5b9e\u4e16\u754c\u7684\u53cd\u9988\u3002<\/p>\n<p>\u5b83\u8fd8\u5c06\u652f\u6301\u7b2c\u4e8c\u9636\u6bb5\u7814\u7a76\u7684\u4ef7\u503c\u4f18\u5148\u6307\u6807\uff0c\u5e76\u534f\u52a9\u63a2\u7d22B\u7c7b\u5904\u65b9\u7279\u522b\u51c6\u5165\u8ba1\u5212\u7684\u6f5c\u529b\u3002<\/p>\n<p>Gavin\u535a\u58eb\u8868\u793a\uff0c\u690d\u5165\u7684\u6536\u76ca\u5c06\u63a8\u52a8Avecho\u7684\u5927\u9ebb\u7d20\u9879\u76ee\u8d85\u8d8a\u8fd9\u4e00\u8bd5\u9a8c\u548c\u7b2c\u4e00\u9636\u6bb5PK\u7814\u7a76\uff0c\u540e\u8005\u6b63\u5904\u4e8e\u8ba1\u5212\u7684\u6700\u540e\u9636\u6bb5\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u5b83\u5c06\u652f\u6301\u5236\u836fCBD TPM\u5242\u578b\u7684\u6700\u7ec8\u786e\u5b9a\uff0c\u53ef\u80fd\u8fdb\u884c\u7684II\/III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u53ca\u5f00\u53d1\u63d0\u4ea4\u7684\u6ce8\u518c\u6863\u6848\u3002\u201d<\/p>\n<p>\u4ed6\u8865\u5145\u8bf4\uff0c\u8fd9\u9879\u5de5\u4f5c\u7684\u8ba1\u5212\u5c06\u4e0e\u6b63\u5728\u8fdb\u884c\u7684\u7814\u7a76\u540c\u65f6\u8fdb\u884c\u3002<\/p>\n<h2>\u5927\u9ebb\u4e8c\u915aTPM\u914d\u65b9\u7684\u5185\u5728\u4ef7\u503c<\/h2>\n<p>Avecho\u76f8\u4fe1\u5176\u5927\u9ebb\u7d20TPM\u914d\u65b9\u5177\u6709\u5185\u5728\u4ef7\u503c\uff0c\u6fb3\u5927\u5229\u4e9a\u6cbb\u7597\u836f\u54c1\u7ba1\u7406\u5c40(Therapeutic Good Administration)\u73b0\u5728\u5141\u8bb8\u6ce8\u518c\u5927\u9ebb\u7d20\u4ea7\u54c1\u6bcf\u65e5\u6700\u5927\u5242\u91cf\u4e3a150\u6beb\u514b\uff0c\u65e0\u9700\u5904\u65b9\u5373\u53ef\u76f4\u63a5\u4ece\u836f\u5242\u5e08\u5904\u8d2d\u4e70\u3002<\/p>\n<p>Gavin\u535a\u58eb\u89e3\u91ca\u8bf4:\u201c\u5927\u9ebb\u7d20(\u5242\u91cf)\u7684\u4e0b\u8c03\u5bf9\u60a3\u8005\u6765\u8bf4\u662f\u4e2a\u597d\u6d88\u606f\uff0c\u4f46150mg\u7684\u5242\u91cf\u5bf9\u4e00\u7cfb\u5217\u9002\u5e94\u75c7\u7684\u7597\u6548\u662f\u6709\u9650\u7684\u3002\u201d<\/p>\n<p>\u4ed6\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u76f8\u4fe1\uff0c\u63d0\u9ad8\u751f\u7269\u5229\u7528\u5ea6\u5c06\u662f\u4e00\u4e2a\u5173\u952e\u7684\u4ef7\u503c\u9a71\u52a8\u56e0\u7d20\uff0c\u5b83\u5c06\u4f7f\u6211\u4eec\u7684\u4ea7\u54c1\u5728\u8fd9\u4e2a\u65e5\u76ca\u6fc0\u70c8\u7684\u5e02\u573a\u4e2d\u8131\u9896\u800c\u51fa\u3002\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002 \u5728\u6b64\u4e4b\u524d\uff0c\u4e0a\u5468\u6709\u6d88\u606f\u79f0\uff0c\u5168\u7403\u5de8\u5934Jazz Pharmaceuticals\u63d0\u51fa\u4ee572\u4ebf\u7f8e\u5143\u6536\u8d2dGW\u5236\u836f\u516c\u53f8\uff0c\u540e\u8005\u62e5\u6709\u5927\u91cf\u7684\u5927\u9ebb\u7c7b\u5019\u9009\u836f\u7269\u3002GW\u8fd8\u62e5\u6709\u57fa\u4e8e\u5927\u9ebb\u7d20\u7684\u836f\u7269Epidiolex\uff0c\u8fd9\u662f\u7b2c\u4e00\u4e2a\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(FDA)\u6279\u51c6\u7684\u57fa\u4e8e\u690d\u7269\u7684\u5927\u9ebb\u7d20\u836f\u7269\u3002 \u968f\u7740\u5168\u7403\u5bf9\u5927\u9ebb\u7c7b\u836f\u7269\u7684\u5173\u6ce8\u518d\u6b21\u805a\u7126\uff0cAvecho\u83b7\u5f97\u4e86506\u4e07\u6fb3\u5143\u7684\u878d\u8d44\uff0c\u540c\u65f6\u4e5f\u83b7\u5f97\u4e86100\u4e07\u6fb3\u5143\u7684\u6295\u8d44\u57fa\u91d1Horizon 3 Biotech\u7684\u6ce8\u518c\u8d44\u91d1\u3002 Avecho\u4ee5\u6bcf\u80a10.022\u6fb3\u5143\u7684\u4ef7\u683c\u53d1\u884c\u4e862.3\u4ebf\u80a1\u80a1\u7968\uff0c\u4ee5\u7b79\u96c6506\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\u3002\u671f\u6743\u7684\u6267\u884c\u4ef7\u683c\u4e3a\u6bcf\u80a10.035\u6fb3\u5143\uff0c\u6709\u6548\u671f\u4e3a2023\u5e7412\u670831\u65e5\u3002 Peak Asset Management\u62c5\u4efb\u6b64\u6b21\u914d\u80a1\u7684\u4e3b\u7ecf\u7406\uff0c\u5e76\u627f\u9500\u4e86\u53e6\u5916400\u4e07\u6fb3\u5143\u3002\u52302\u67089\u65e5\u4ea4\u6613\u7ed3\u675f\u65f6\uff0c\u6b64\u6b21\u914d\u552e\u5df2\u6536\u5230\u8d85\u8fc72300\u4e07\u6fb3\u5143\u7684\u6295\u6807\u3002 Avecho\u9996\u5e2d\u6267\u884c\u5b98Paul Gavin\u535a\u58eb\u8868\u793a\uff0c\u516c\u53f8\u201c\u975e\u5e38\u611f\u8c22\u201d\u73b0\u6709\u80a1\u4e1c\u3001\u65b0\u6210\u719f\u6295\u8d44\u8005\u548c\u4e13\u4e1a\u57fa\u91d1\u7684\u201c\u5927\u529b\u652f\u6301\u201d\u3002 \u201c\u4e00\u6bb5\u65f6\u95f4\u4ee5\u6765\uff0c\u6211\u4eec\u4e00\u76f4\u5728\u89c2\u5bdf\u4eba\u4eec\u5bf9\u836f\u7528\u5927\u9ebb\u7d20\u7684\u5174\u8da3\u4e0d\u65ad\u589e\u957f\uff0c\u6211\u4eec\u6536\u5230\u7684\u53cd\u54cd\u8868\u660e\uff0c\u8fd9\u4e00\u9886\u57df\u6b63\u5728\u5f62\u6210\u5f3a\u5927\u7684\u5546\u4e1a\u52bf\u5934\u3002\u201d \u5927\u9ebb\u7d20\u5236\u836f\u53d1\u5c55 Avecho\u5c06\u5229\u7528\u8fd9\u7b14\u8d44\u91d1\u8fdb\u4e00\u6b65\u5f00\u53d1\u548c\u6ce8\u518c\u8be5\u516c\u53f8\u65b0\u7684\u533b\u836f\u7ea7\u5927\u9ebb\u7d20\u4ea7\u54c1\u3002 \u53bb\u5e74\u5e74\u5e95\uff0cAvecho\u542f\u52a8\u4e86\u57fa\u4e8e\u5176\u4e13\u5229\u836f\u7269\u9012\u9001\u7cfb\u7edfTPM(\u751f\u80b2\u915a\u78f7\u9178\u76d0\u6df7\u5408\u7269)\u7684\u53e3\u670d\u5927\u9ebb\u7d20\u5236\u5242\u7684\u4e34\u5e8a\u6d4b\u8bd5\u3002 TPM\u8f93\u9001\u7cfb\u7edf\u662f\u4f7f\u7528\u72ec\u7279\u7684\u4e13\u5229\u548c\u4e13\u5229\u5de5\u827a\u4ece\u7ef4\u751f\u7d20E\u4e2d\u884d\u751f\u51fa\u6765\u7684\u3002 \u6839\u636eAvecho\u7684\u8bf4\u6cd5\uff0cTPM\u53ef\u4ee5\u63d0\u9ad8\u836f\u7269\u548c\u8425\u517b\u7269\u8d28\u7684\u6eb6\u89e3\u5ea6\u4ee5\u53ca\u53e3\u670d\u3001\u76ae\u80a4\u548c\u900f\u76ae\u5438\u6536\u3002 Avecho\u7684\u7814\u7a76\u662f\u6fb3\u5927\u5229\u4e9a\u6700\u5927\u7684\u836f\u7528\u5927\u9ebb\u4ea7\u54c1\u8fd0\u884c\u89c2\u5bdf\u6027\u7814\u7a76\u2014\u2014CA\u8bca\u6240\u89c2\u5bdf\u6027\u7814\u7a76\u7684\u4e00\u90e8\u5206\u3002 \u8be5\u516c\u53f8\u9884\u8ba1\uff0c\u8fd9\u6b21\u8bd5\u9a8c\u5c06\u5bf9\u4ea7\u54c1\u7684\u8fdb\u4e00\u6b65\u53d1\u5c55\u4ea7\u751f\u5f71\u54cd\uff0c\u5e76\u63d0\u4f9b\u771f\u5b9e\u4e16\u754c\u7684\u53cd\u9988\u3002 \u5b83\u8fd8\u5c06\u652f\u6301\u7b2c\u4e8c\u9636\u6bb5\u7814\u7a76\u7684\u4ef7\u503c\u4f18\u5148\u6307\u6807\uff0c\u5e76\u534f\u52a9\u63a2\u7d22B\u7c7b\u5904\u65b9\u7279\u522b\u51c6\u5165\u8ba1\u5212\u7684\u6f5c\u529b\u3002 Gavin\u535a\u58eb\u8868\u793a\uff0c\u690d\u5165\u7684\u6536\u76ca\u5c06\u63a8\u52a8Avecho\u7684\u5927\u9ebb\u7d20\u9879\u76ee\u8d85\u8d8a\u8fd9\u4e00\u8bd5\u9a8c\u548c\u7b2c\u4e00\u9636\u6bb5PK\u7814\u7a76\uff0c\u540e\u8005\u6b63\u5904\u4e8e\u8ba1\u5212\u7684\u6700\u540e\u9636\u6bb5\u3002 \u4ed6\u8bf4:\u201c\u5b83\u5c06\u652f\u6301\u5236\u836fCBD TPM\u5242\u578b\u7684\u6700\u7ec8\u786e\u5b9a\uff0c\u53ef\u80fd\u8fdb\u884c\u7684II\/III\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u53ca\u5f00\u53d1\u63d0\u4ea4\u7684\u6ce8\u518c\u6863\u6848\u3002\u201d \u4ed6\u8865\u5145\u8bf4\uff0c\u8fd9\u9879\u5de5\u4f5c\u7684\u8ba1\u5212\u5c06\u4e0e\u6b63\u5728\u8fdb\u884c\u7684\u7814\u7a76\u540c\u65f6\u8fdb\u884c\u3002 \u5927\u9ebb\u4e8c\u915aTPM\u914d\u65b9\u7684\u5185\u5728\u4ef7\u503c Avecho\u76f8\u4fe1\u5176\u5927\u9ebb\u7d20TPM\u914d\u65b9\u5177\u6709\u5185\u5728\u4ef7\u503c\uff0c\u6fb3\u5927\u5229\u4e9a\u6cbb\u7597\u836f\u54c1\u7ba1\u7406\u5c40(Therapeutic Good Administration)\u73b0\u5728\u5141\u8bb8\u6ce8\u518c\u5927\u9ebb\u7d20\u4ea7\u54c1\u6bcf\u65e5\u6700\u5927\u5242\u91cf\u4e3a150\u6beb\u514b\uff0c\u65e0\u9700\u5904\u65b9\u5373\u53ef\u76f4\u63a5\u4ece\u836f\u5242\u5e08\u5904\u8d2d\u4e70\u3002 Gavin\u535a\u58eb\u89e3\u91ca\u8bf4:\u201c\u5927\u9ebb\u7d20(\u5242\u91cf)\u7684\u4e0b\u8c03\u5bf9\u60a3\u8005\u6765\u8bf4\u662f\u4e2a\u597d\u6d88\u606f\uff0c\u4f46150mg\u7684\u5242\u91cf\u5bf9\u4e00\u7cfb\u5217\u9002\u5e94\u75c7\u7684\u7597\u6548\u662f\u6709\u9650\u7684\u3002\u201d \u4ed6\u8865\u5145\u8bf4:\u201c\u6211\u4eec\u76f8\u4fe1\uff0c\u63d0\u9ad8\u751f\u7269\u5229\u7528\u5ea6\u5c06\u662f\u4e00\u4e2a\u5173\u952e\u7684\u4ef7\u503c\u9a71\u52a8\u56e0\u7d20\uff0c\u5b83\u5c06\u4f7f\u6211\u4eec\u7684\u4ea7\u54c1\u5728\u8fd9\u4e2a\u65e5\u76ca\u6fc0\u70c8\u7684\u5e02\u573a\u4e2d\u8131\u9896\u800c\u51fa\u3002\u201d<\/p>\n","protected":false},"author":3,"featured_media":10773,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[130],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1<\/title>\n<meta name=\"description\" content=\"\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1\" \/>\n<meta property=\"og:description\" content=\"\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-10T03:08:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:48:28+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Avecho-Biotechnology-ASX-AVE-placement-pharmaceutical-cannabinoid-program.jpg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1\" \/>\n<meta name=\"twitter:description\" content=\"\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Avecho-Biotechnology-ASX-AVE-placement-pharmaceutical-cannabinoid-program.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/\",\"name\":\"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-02-10T03:08:05+00:00\",\"dateModified\":\"2023-08-29T17:48:28+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1","description":"\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1","og_description":"\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/","og_site_name":"smallcapsCN","article_published_time":"2021-02-10T03:08:05+00:00","article_modified_time":"2023-08-29T17:48:28+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Avecho-Biotechnology-ASX-AVE-placement-pharmaceutical-cannabinoid-program.jpg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1","twitter_description":"\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Avecho-Biotechnology-ASX-AVE-placement-pharmaceutical-cannabinoid-program.jpg","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/","url":"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/","name":"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-02-10T03:08:05+00:00","dateModified":"2023-08-29T17:48:28+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u968f\u7740\u5168\u7403\u836f\u7528\u5927\u9ebb\u9886\u57df\u7684\u6210\u719f\uff0cAvecho Biotechnology (ASX: AVE)\u901a\u8fc7\u8d85\u989d\u8ba4\u8d2d\u83b7\u5f97\u4e86\u8d85\u8fc7500\u4e07\u6fb3\u5143\u7684\u8d44\u91d1\uff0c\u7528\u4e8e\u63a8\u8fdb\u5176\u836f\u7528\u5927\u9ebb\u7d20\u9879\u76ee\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/avecho-biotechnology-raises-develop-pharmaceutical-cannabinoid-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Avecho Biotechnology\u7b79\u96c6506\u4e07\u6fb3\u5143\u7528\u4e8e\u5f00\u53d1\u836f\u7269\u5927\u9ebb\u7d20\u4ea7\u54c1"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2640"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2640"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2640\/revisions"}],"predecessor-version":[{"id":10772,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2640\/revisions\/10772"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10773"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}